Proteomic analysis of mitochondria from infantile hemangioma endothelial cells treated with sodium morrhuate and its liposomal formulation

Journal of Biochemical and Molecular Toxicology

Volumn 26, Issue 9, 2012, Pages 374-380

  Tu, Jun Bo ^a   Dong, Qiang ^a   Hu, Xiao Yi ^a   Jiang, Fei ^a   Ma, Rui Zhao ^a   He, Lin Ying ^b   Yang, Zhuang Qun ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hemangioma; Mitochondria; Proteomics; Sodium Morrhuate

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 8; CYTOCHROME C1; LAMIN B; LAMIN B1; MESSENGER RNA; MORRHUATE SODIUM; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CAPILLARY HEMANGIOMA; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASE 8; CELL SHAPE; CYTOCHROMES C1; DRUG COMPOUNDING; ENDOTHELIAL CELLS; GENE EXPRESSION; HEMANGIOMA; HUMANS; INFANT; LAMIN TYPE B; LIPOSOMES; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEOME; PROTEOMICS; SODIUM MORRHUATE; TUMOR CELLS, CULTURED;

EID: 84866438178     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21436     Document Type: Article

References (28)

1. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
2. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107:745-752.
3. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993;6:204-218.
4. Bischoff J. Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences? Trends Cardiovasc Med 2002;12:220-224.
5. Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JW, Reinisch JF, Marchuk DA. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33:295-303.
6. Mendiratta V, Jabeen M. Infantile hemangioma: an update. Indian J Dermatol Venereol Leprol 2010;76:469-475.
7. Mabeta P, Pepper MS. Hemangiomas-current therapeutic strategies. Int J Dev Biol 2011;55:431-437.
8. Itinteang T, Withers AH, Leadbitter P, Day DJ, Tan ST. Pharmacologic therapies for infantile hemangioma: is there a rational basis? Plast Reconstr Surg 2011;128:499-507.
9. Li L, Zeng XQ, Li YH. Safety and effectiveness of transcatheter foam sclerotherapy for testicular varicocele with a fluoroscopic tracing technique. J Vasc Interv Radiol 2010;21:824-828.
10. Marcus A, Moore CE. Sodium morrhuate sclerotherapy for the treatment of benign lymphoepithelial cysts of the parotid gland in the HIV patient. Laryngoscope 2005;115:746-749.
11. Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 2004;33:463-466.
12. Yang ZQ, Song Y, Tu JB, Wang ZH, Ma JM, Lan HL, Xu Q, Li P. Study of immunolipo-sodium morrhuate applied on human hemangioma endothelial cells in vitro. Shanghai Journal of Stomatology 2008;17:143-150.
13. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516.
14. Garcia-Marco JA, Panizo C, Garcia ES, Deben G, Alvarez-Larran A, Barca EG, Sancho JM, Penarrubia MJ, Garcia-Cerecedo T, Garcia Vela JA. Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma. Cancer 2009;115:1892-1898.
15. Batist G, Gelmon KA, Chi KN, Miller WH Jr, Chia SK, Mayer LD, Swenson CE, Janoff AS, Louie AC. Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clin Cancer Res 2009;15:692-700.
16. Harach HR, Jasani B, Williams ED. Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid. J Clin Pathol 1983;36:1050-1054.
17. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
19. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004;16:663-669.
20. Lemasters JJ. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999;276:G1-G6.
21. Henriquez M, Armisén R, Stutzin A, Quest AF. Cell death by necrosis, a regulated way to go. Curr Mol Med 2008;8:187-206.
22. Crawford AC, Riggins RB, Shajahan AN, Zwart A, Clarke R. Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis. PLoS One 2010;5: e8604.
23. Liu FT, Kelsey SM, Newland AC, Jia L. Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells. Br J Haematol 2002;117:333-342.
24. Tu JB, Lan HL, Yang ZQ, Zhang TL, Song Y, Xing Z. Compare the effect of lipo- and normal prepared sodium morrhuate on ECV-304 cell line. Hua Xi Kou Qiang Yi Xue Za Zhi 2006;24:491-494.
25. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99-163.
26. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-446.
27. Sato A, Satake A, Hiramoto A, Okamatsu A, Nakama K, Kim HS, Wataya Y. Association of nuclear-intermediate filament lamin B1 with necrotic- and apoptotic-morphologies in cell death induced by 5-fluoro-2′-deoxyuridine. Nucleic Acids Symp Ser (Oxf) 2009;293-294.
28. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep 2012;32:1-15.